Skip to main content

NMPA Expedited Approval

Meaning

NMPA Expedited Approval refers to a regulatory pathway established by the National Medical Products Administration (NMPA) in China, designed to accelerate the review and approval process for new drugs and medical devices that address an urgent clinical need or offer a significant therapeutic advantage over existing treatments. This designation is strategically important for companies seeking rapid market access for innovative hormonal therapies or diagnostic tools. It signifies a priority status in the regulatory queue.